Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115573) titled 'Interpretable AI Model Based on Radiogenomics for Early Intelligent Prediction of Radioactive Iodine-Refractory Differentiated Thyroid Cancer' on Dec. 29, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Thyroid cancer
Intervention:
Radioactive iodine-refractory differentiated thyroid cancer:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Radioactive iodine-refractory differentiated thyroid cancer:500;None radioactive iodine-refractory differentiated thyroid cancer:5...